Earlier in the day, Biolik said it had not signed any contracts for the production of Sputnik V, but is ready to make a vaccine against coronavirus if it is registered in Ukraine.
"Biolik has the necessary technological capabilities for the production of vaccines based on the human adenoviral vector. At the facilities of the enterprise, the first test dispensing was made, which is technologically identical to the production of the Sputnik V vaccine. The readiness of the plant for the production of the finished form of the vaccine is confirmed by the footage of the technological process," the RDIF said.
"For the supply of raw materials necessary for the manufacture of a vaccine, an appropriate approval must be obtained from the Ukrainian regulator. A request for obtaining the corresponding approval will be submitted in the near future," it added.
"Based on the above, the official press release of the RDIF and the explanation of Biolik JSC do not contradict each other. RDIF and the Gamaleya Institute are ready to organize the production of the Sputnik V vaccine as soon as possible after receiving the necessary approvals from the regulatory authorities of Ukraine," the fund concluded.
